Copyright
©The Author(s) 2020.
World J Gastroenterol. Jan 14, 2020; 26(2): 168-183
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.168
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.168
Figure 5 Serum LncRNAs and mRNA as prognostic biomarker for relapsed patients.
ROC curve analysis for lncRNA Gas 5 (AUC = 0.91) (A), BISPR (AUC = 0.84) (B), HEIH (AUC = 0.95) (C) and mRNA BST2 (AUC = 0.86) (D) as prognostic biomarkers discriminating relapsed from treated from SOF + SIM patients.
- Citation: El Samaloty NM, Shabayek MI, Ghait RS, El-Maraghy SA, Rizk SM, El-Sawalhi MM. Assessment of lncRNA GAS5, lncRNA HEIH, lncRNA BISPR and its mRNA BST2 as serum innovative non-invasive biomarkers: Recent insights into Egyptian patients with hepatitis C virus type 4. World J Gastroenterol 2020; 26(2): 168-183
- URL: https://www.wjgnet.com/1007-9327/full/v26/i2/168.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i2.168